1,283
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Galangin alleviates rheumatoid arthritis in rats by downregulating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway

, , , &
Pages 11192-11201 | Received 31 Oct 2021, Accepted 01 Apr 2022, Published online: 29 Apr 2022

References

  • Chang X, Luo F, Jiang W, et al. Protective effect of apigenin on Freund’s complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathway. Int Immunopharmacol. 2015;28(1):604–615.
  • Dai Y, Wang W, Yu Y, et al. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Clin Rheumatol. 2021;40(4):1211–1220.
  • Philippou E, Petersson SD, Rodomar C, et al. Rheumatoid arthritis and dietary interventions: systematic review of clinical trials. Nutr Rev. 2021;79(4):410–428.
  • Harrold LR, Reed GW, Kremer JM, et al. Identifying factors associated with concordance with the American college of rheumatology rheumatoid arthritis treatment recommendations. Arthritis Res Ther. 2016;18(1):94.
  • Wu Z, Ma D, Yang H, et al. Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol. 2021;93:107392.
  • de Sousa EB, Casado PL, Moura Neto V, et al. Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Res Ther. 2014;5(5):112.
  • Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361.
  • Malemud CJ. The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? Future Med Chem. 2015;7(9):1137–1147.
  • Rampogu S, Gajula RG, Lee KW. A comprehensive review on chemotherapeutic potential of galangin. Biomed Pharmacother. 2021;141:111808.
  • Fang D, Xiong Z, Xu J, et al. Chemopreventive mechanisms of galangin against hepatocellular carcinoma: a review. Biomed Pharmacother. 2019;109:2054–2061.
  • Cai SQ, Zhang Q, Zhao XH, et al. The in vitro anti-inflammatory activities of galangin and quercetin towards the LPS-Injured Rat Intestinal Epithelial (IEC-6) cells as affected by heat treatment. Molecules. 2021;26(24):7495.
  • Kim HH, Bae Y, Kim SH. Galangin attenuates mast cell-mediated allergic inflammation. Food Chem Toxicol. 2013;57:209–216.
  • Zha WJ, Qian Y, Shen Y, et al. Galangin abrogates ovalbumin-induced airway inflammation via negative regulation of NF-kappaB. Evid Based Complement Alternat Med. 2013;2013:767689.
  • Fu Q, Gao Y, Zhao H, et al. Galangin protects human rheumatoid arthritis fibroblast-like synoviocytes via suppression of the NF-κB/NLRP3 pathway. Mol Med Rep. 2018;18(4):3619–3624.
  • Chen S. Natural products triggering biological targets–a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets. 2011;12(3):288–301.
  • Wang S, Zha X, Ruan S, et al. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis. Bioengineered. 2022;13(1):1779–1790.
  • Guan S, Jin T, Han S, et al. Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells. Bioengineered. 2021;12(2):9401–9410.
  • Wu LY, Chen CW, Chen LK, et al. Curcumin attenuates adipogenesis by inducing preadipocyte apoptosis and inhibiting adipocyte differentiation. Nutrients. 2019;11(10):2307.
  • Du Y, Du T, Shi Y, et al. Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages. Antiviral Res. 2016;131:9–18.
  • Zhu G, Shen Q, Jiang H, et al. Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling. Pharm Biol. 2020;58(1):25–34.
  • Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011;84(11):1245–1252.
  • Kapoor S, Fitzpatrick M, Clay E, et al. Metabolomics in the analysis of inflammatory disease. In: Roessner U, Editors. Metabolomics. Wellcome trust-funded monographs and book chapters . Rijeka (HR); 2012;Feb 10. Chapter 11. PMID: 28045482.
  • Song HY, Kim WS, Han JM, et al. Galangin treatment during dendritic cell differentiation confers tolerogenic properties in response to lipopolysaccharide stimulation. J Nutr Biochem. 2021;87:108524.
  • Li J, Jiang H, Wu P, et al. Toxicological effects of deltamethrin on quail cerebrum: weakened antioxidant defense and enhanced apoptosis. Environ Pollut. 2021;286:117319.
  • Qu W, Jiang L, Hou G. Circ-AFF2/miR-650/CNP axis promotes proliferation, inflammatory response, migration, and invasion of rheumatoid arthritis synovial fibroblasts. J Orthop Surg Res. 2021;16(1):165.
  • Bi X, Guo XH, Mo BY, et al. LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis. EBioMedicine. 2019;50:408–420.
  • Zhang X, Nan H, Guo J, et al. NLRP12 reduces proliferation and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by regulating the NF-κB and MAPK pathways. Eur Cytokine Netw. 2021;32(2):15–22.
  • Lv Y, Jiang H, Li S, et al. Sulforaphane prevents chromium-induced lung injury in rats via activation of the Akt/GSK-3β/Fyn pathway. Environ Pollut. 2020;259:113812.
  • Atzeni F, Talotta R, Masala IF, et al. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res Clin Rheumatol. 2018;32(4):500–510.
  • Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019;59:125–132.
  • Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452.
  • Tokuhira N, Kitagishi Y, Suzuki M, et al. PI3K/AKT/PTEN pathway as a target for Crohn’s disease therapy (Review). Int J Mol Med. 2015;35(1):10–16.
  • Canaud G, Bienaime F, Tabarin F, et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014;371(4):303–312.